CD4 and neoplasm: PSSN10 efficiently delivered both NLG and DOX to the tumor tissue. PSSN10 stimulated higher percentage of functional T cells (CD4+ and CD8+) and lowered percentages of Treg cells and MDSCs with DOX or DOXIL